Study details
Enrolling now
Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder
Yale University
NCT IDNCT06142955ClinicalTrials.gov data as of Apr 2026
Target enrollment
60
Study length
about 2.7 years
Ages
18–40
Locations
1 site in CT
What this study is about
Researchers are testing if a treatment called TMS can help with depression in people who have autism. The treatment uses a device that sends magnetic pulses to the brain. The trial will measure changes in behavior and brain activity before and after the treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use MAGSTIM Rapid2 TMS system
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Devices
therapeutic
Body systems
Psychiatry / Mental Health